Xencor (XNCR) Capital Expenditures (2013 - 2026)

Xencor's (XNCR) quarterly Capital Expenditures came in at $610000.0 in Q1 2026, down 57.76% year-on-year from $1.4 million in Q1 2025, and down 46.49% on a QoQ basis from $1.1 million in Q4 2025.

Xencor (XNCR) Capital Expenditures (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Capital Expenditures data on file, last reported at $610000.0 in Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 57.76% year-over-year to $610000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 68.74% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, down 48.34% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $610000.0, down from $1.1 million in the prior quarter.
  • Over the last five years, Capital Expenditures for XNCR reached as high as $14.1 million in Q3 2022 and fell as low as $132000.0 in Q1 2024.
  • Historically, Capital Expenditures has averaged $3.9 million across 5 years, with a median of $1.7 million in 2024.
  • Across the five-year window, Capital Expenditures plunged 98.78% in 2024 and surged 993.94% in 2025, its largest moves.
  • Year by year, Capital Expenditures stood at $10.0 million in 2022, then plunged by 90.17% to $980000.0 in 2023, then jumped by 69.8% to $1.7 million in 2024, then tumbled by 31.49% to $1.1 million in 2025, then plunged by 46.49% to $610000.0 in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $610000.0 in Q1 2026, $1.1 million in Q4 2025, and $183000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Xencor 1.47 Bn 1.09 Bn - 610,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 610,000.00
Mar 31, 2026 610,000.00
Dec 31, 2025 1.14 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 183,000.00
Sep 30, 2025 183,000.00
Jun 30, 2025 383,000.00
Jun 30, 2025 383,000.00
Mar 31, 2025 1.44 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 1.66 Mn
Dec 31, 2024 1.66 Mn
Sep 30, 2024 1.28 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 3.03 Mn
Jun 30, 2024 3.03 Mn
Mar 31, 2024 132,000.00
Mar 31, 2024 132,000.00
Dec 31, 2023 980,000.00
Dec 31, 2023 980,000.00